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SUMMARY
Fenbendazole (FBZ) is an anthelmintic recently approved to treat and control nematode
infections in growing turkeys. When administered to growing turkeys there are no detrimental
side effects. However, when we used FBZ to treat nematodes in mature breeder toms, we observed
a decrease in semen quality and a subsequent precipitous decline in fertility to less than 20%
within 6 wk of administration. An experiment was designed to determine the impact of FBZ
administration on aspects of spermatogenesis and semen quality. We discovered that although
sperm viability and concentration was not significantly affected by FBZ, this drug significantly
reduced sperm mobility. However, normal mobility resumed within 6 wk after FBZ administration.
Fenbendazole binds to tubulin and interferes with microtubule assembly. Based on testes histology
and the immunocytochemical localization of tubulin in spermatids and mature sperm, FBZ had
no affect on any aspect of spermatogenesis. We suggest that FBZ may be affecting sperm mobility
by some molecular alteration of the sperm tail axoneme or midpiece, both of which are tubulin-
containing structures. If a breeding flock of toms become infected with nematode parasites, a flock
manager has the following options: do not treat the toms, find an alternative to FBZ, treat the
toms with FBZ and increase the sperm number and frequency of artificial inseminations, or treat
the toms with FBZ and secure semen from an uninfected tom flock.
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DESCRIPTION OF PROBLEM
Fenbendazole (FBZ) is a benzimidazole
antihelmintic used in domesticated animals for
the treatment and control of nematode parasites
and has recently been approved and labeled for
growing turkeys. Apparently, FBZ is poorly ab-
sorbed by the host animal and selectively ab-
sorbed by the nematode parasite. When internal-
ized by the nematode parasite, FBZ binds to
the tubulin molecule and consequently interferes
with the polymerization of tubulin into microtu-
bules [1].
Faced with a roundworm outbreak in our
turkey breeder farm, FBZ was administered at
1Corresponding author: murray@anri.barc.usda.gov
the approved dose rate by the resident veterinar-
ian at the dose recommended by the manufac-
turer. Within a 2-wk period, sperm mobility was
noticeably impaired, and true fertility declined
precipitously from 83% the week of FBZ admin-
istration to 55% the second week and to 16%
by 7 wk later. The hatchability of fertile eggs
remained unchanged.
Nothing was found in the literature on the
effects of FBZ administration on breeder toms.
In contrast, FBZ has been shown to have no
adverse effects on semen quality or fertility in
cattle, sheep, or swine [2]. In the following com-
munication, we describe results of a study in
Journal of Applied Poultry Research 15:2 (2006), pp. 307-311.
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which FBZ has a rapid, long-term, but transitory
effect on semen quality when administered to
mature toms.
MATERIALS AND METHODS
Hybrid turkey toms (n = 40) were raised
and maintained under management conditions
recommended by the Hybrid breeder manual [3].
Semen was collected from all toms for 2 wk (28
to 30 wk) and collected twice weekly thereafter.
Twenty males were randomly chosen from the
tom flock and given FBZ at the dosage recom-
mended by the resident veterinarian (8 g of FBZ
20% premix /kg of feed, fed for 6 d). Semen
collection continued unabated for the next 6 wk.
Fourteen toms from the control and FBZ treat-
ment groups were killed at intervals during the
6-wk period for tissue collection. Semen samples
from individual control (n = 6) and FBZ-treated
toms (n = 6) were evaluated separately for sperm
concentration, membrane integrity, and sperm
mobility. Sperm concentration was determined
using an IMV Microreader photometer (optical
density of 597 nm) [4] to estimate the optical
density of a 1:200 dilution of neat semen in
a 3% (wt/vol) sodium citrate solution. Sperm
viability was determined using the SYBR-14–
propridium iodide live-dead stain combination
as evaluated by flow cytometry [5]. Sperm mo-
bility was assessed as previously described by
Froman and McLean [6] with the minor modifi-
cations suggested by Long and Kulkarni [7].
Briefly, a sperm suspension (1 × 109 sperm/
mL of mobility buffer) was overlaid onto a 6%
Accudenz solution and incubated for 5 min at
41°C. The optical density was measured by an
IMV Microreader photometer (optical density
of 597 nm) after 1 min of equilibration; sperm
mobility values are presented as absorbance
units.
Testicular histology was conducted on 3 to
4 males per week from 34 wk of age (2 wk
before FBZ treatment) through 44 wk of age (8
wk after FBZ treatment). Toms were euthanized
by cervical dislocation, and the left testes were
removed and fixed in 6% formaldehyde in PBS.
After fixation for 24 h, the specimens were pre-
pared for paraffin embedding, sectioned at 6 to
7 m, and mounted on Fisher Superfrost Plus
slides [8]. Sections were stained with hematoxy-
lin and eosin for general histology and immuno-
cytochemically stained for tubulin localization.
After dewaxing, the sections were stained with
fluorescein-isothiocyanate (FITC)-conjugated
anti-tubulin and examined with a Zeiss Axiomat.
For immunocytochemistry, sections were per-
meablized with 0.1% Triton X-100 for 18 h at
4°C and then washed for 2 h at room temperature
in 1% BSA in 0.4% polyvinylpyrrolidone in
buffer. Sections were then flooded with mouse
anti-α-tubulin or β-tubulin at 1:1,000 and 1:500,
respectively, for 12 h at 4°C and washed in
buffer for 4 h. Sections were then flooded with
goat anti-mouse IgG-conjugated FITC overnight
at 4°C and washed in buffer for 4 h. To visualize
nuclei, sections were stained with bis-benzimide
(final concentration of 5 g/mL of buffer) for
10 min at ambient temperature, rinsed in distilled
water, air-dried, and cover-slipped with Vectas-
hield mounting medium.
Statistical Analysis
Three statistical analyses were performed on
the data collected. Percentage of sperm viability
was arcsine transformed [z = sine−1√(y/100),
where y is the data value measured as a percent-
age, and z is the transformed variable used in
the analysis] to stabilize the variance and satisfy
ANOVA assumptions. Sperm concentration and
mobility were not transformed. For each tom, 3
wk of pretreatment values were averaged, trans-
formed if they represented percentages (sperm
viability), and used as covariates to adjust the
subsequent values for each tom. A mixed model
ANOVA was performed for each of the 3 depen-
dent variables, using PROC MIXED in SAS [9].
The independent variables in the model were
the covariate, a treatment effect, a week (time)
effect, and a week-by-treatment interaction. The
time series dependencies resulting from repeat-
edly measuring each tom were modeled using
an autoregressive (1) covariance structure. De-
grees of freedom were computed using the Ken-
wood-Rogers estimate [9]. Least squares means
and their standard errors were also calculated
by the PROC MIXED SAS subroutine. For per-
centage of viable sperm, an approximate 95%
confidence interval on each mean was calculated
on the transformed scale. The means and 95%
confidence intervals were then back-transformed
to the percentage scale for ease of interpretation.
If a significant treatment effect was observed, we
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also expected a treatment by week interaction,
because the effect of the FBZ administration on
semen quality should diminish over time.
RESULTS AND DISCUSSION
After administration of FBZ, semen quality
decreased within 2 wk. Sperm mobility signifi-
cantly decreased (F1, 20.5 = 33.77, P < 0.01) the
second week after FBZ administration and re-
mained quite low for the next 2 wk. There was
a significant treatment-by-week interaction
(F6,52.4 = 2.54, P = 0.03) for mobility, interpreted
as the treatment effect gradually wearing off
following the FBZ administration (Figure 1a)
because sperm mobility in the treatment group
increased with time since treatment. Control
sperm mobility declined slightly over the course
of the experiment. The overall week effect was
not significant (F6, 52.4 = 0.86, P = 0.53). [Note
that the week effect does not test for this decline
because it pools both control (for which mobility
gradually declined) and treatment (for which
mobility gradually increased after the initial de-
cline) groups.] A pretreatment mobility mean for
a tom was a significant predictor of subsequent
mobility scores (F1, 21.1 = 14.56, P < 0.01).
There was no detectable effect of the FBZ
administration on any other predictor variable
for sperm viability (Figure 1b) and concentration
(Figure 1c), including the pretreatment means,
used as covariates. Thus, for these variables, the
pretreatment mean of a tom was not a good
predictor of subsequent scores. There was an
overall slight (but not significant) decrease in
sperm concentration over time.
Histologically, the seminiferous epithelium
and the interstitial spaces in tissue sections from
FBZ treated and control toms revealed no notice-
able variation in appearance. Given its negative
impact on sperm mobility and that FBZ binds
to the tubulin protein and interferes with poly-
merization of tubulin into microtubules [1], we
focused our attention on 2 tubulin-containing
cell structures: the manchette of tubules [10]
found in elongating spermatids and the axoneme
found in the sperm tail. The immunocytochemi-
cal localization of tubulin revealed a strong posi-
tive reaction product around the elongating nu-
clei in spermatids and to a lesser extent, around
the forming spermatid tails regardless of treat-
ment (Figure 2). In dual fluorescent stain prepa-
Figure 1. Panel A: least squares means of sperm mobil-
ity for control toms (open circles, n = 6) and toms treated
with fenbendazole (closed circles, n = 6) over time.
Bars represent one standard error of the mean in each
direction. Panel B: least squares means of the percent-
age of viable sperm. Bars represent 95% confidence
intervals on the means. Panel C: least squares means
of sperm concentration. Bars represent one standard
error of the mean in each direction.
rations the anti-tubulin-positive manchette ap-
peared to surround the bis-benzimide stained
elongating spermatid nuclei. In anti-tubulin
JAPR: Research Report310
Figure 2. Panel A: a section showing a seminiferous tubule from a tom 4 wk after treatment with fenbenzadole.
Anti-tubulin fluorescence is apparent with the manchette tubules in the elongating spermatids (arrow). Panel B:
the same section as A, showing fluorescing nuclei following staining with the nuclear fluorescent stain bis-benzimide.
The arrow highlights the elongating nucleus that is enveloped by the manchette tubules observed at the arrow in
A. Panel C: tubulin associated with the manchette tubules (arrows) characteristic of the elongating spermatids is
highlighted in this section (control tom). One can visualize the tube-like investment of the manchette enveloping
the elongating nucleus in longitudinal section (upper arrow) and in cross section (lower arrow).
preparations the slight curvature of the man-
chette was observed in longitudinal sections
while its tubular organization was observed in
cross sections (Figure 2c).
Sperm viability and concentration appeared
to be insensitive to FBZ but also did not seem
to differ in a systematic way from among toms
(the pretreatment score of a tom did not predict
subsequent values, even for controls). These
variables may be inherently less valuable for
detecting the effects of medication like FBZ, or
there may be sufficient measurement error or
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other noise to obscure treatment effects. In con-
trast, sperm mobility differences were consistent
between toms, and sperm mobility showed a
clear decrease for those turkeys given this medi-
cation.
The recovery of mobility of sperm as the
time since treatment increased probably re-
flected the gradual replacement of the incapaci-
tated sperm with normal sperm. Figure 1a sug-
gests that this process is essentially complete by
wk 6 after FBZ administration.
If FBZ had an effect on the microtubules
comprising the manchette and sperm tail axo-
neme, it was not evident with the immunocyto-
CONCLUSIONS AND APPLICATIONS
1. In the doses recommended, FBZ reduced sperm mobility and, based on our preliminary observa-
tions, subsequently depressed the percentage of fertile eggs laid by hens inseminated with semen
from the FBZ treated toms for at least 4 wk following FBZ administration.
2. If a tom in semen production became infected with nematode parasites, a flock manager would
have the following options: do not treat the tom; find an alternative to FBZ; treat the tom with
FBZ and increase the sperm number and frequency of artificial inseminations; or treat the tom
with FBZ and secure semen from an uninfected tom flock.
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